Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded an extensive list of Locations across multiple countries and regions. This expands where patients can participate in the trial.SummaryDifference3%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe Publications section text was slightly revised and the page revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check38 days agoChange DetectedThe government funding status notice was removed from the page, which previously warned that information may be out of date due to funding lapses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedNo significant changes detected on the Study Details page for NCT03829319; the content appears unchanged between the two screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange Detected- Updated region name from Rhone-Alpes to Auvergne-Rhône-Alpes and added corresponding address. - Bumped revision from v3.1.0 to v3.2.0. - Added a status notice about government funding and NIH Clinical Center operations.SummaryDifference3%

- Check89 days agoChange DetectedThe page is updated to a newer revision (v3.1.0) with current dates (September 2025) and removes older revision/date markers (v3.0.2 and prior dates). This indicates a fresh release and updated time-related information.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.